Close Menu

NEW YORK (GenomeWeb) – Accelerate Diagnostics reported today that its preliminary second quarter revenues increased significantly to $699,000 from $20,000 driven by sales of the Accelerate Pheno system and Accelerate PhenoTest BC kit.

Analysts on average had expected revenues of $1.6 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.